Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSU6162 PET study of dopamine D2 receptor binding in healthy male volunteers
NL-OMON36314Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of OSU-6162 in Parkinson's disease (PD), sponsored by Vrije University Medical Center. Primary endpoints: Striatal binding potential and Striatal D2 receptor occupancy. Started Jul 2011; status: active, not recruiting.
02
Drugs
OSU-6162
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON36314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36314.